Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008
{{output}}
Introduction: Treatment for metastatic colorectal cancer (mCRC), employing various schedules, combinations, and regimens utilizing 5-fluorouracil (5-FU), irinotecan, oxaliplatin, capecitabine, bevacizumab, and cetuximab, currentl... ...
